Health Education
Assoc. prof. Dr. Walaa
Microbiology
&Immunology
Department
Screening Programs:
A Public Health Strategy
Early Detection and Prevention for Healthier Communities
What is Screening?
"A systematic public health strategy to identify early,
undiagnosed disease or risk factors in apparently healthy
individuals."
• Targets apparently healthy populations
• Identifies risk factors early
• Allows for timely medical intervention
• Prevents clinical symptoms from appearing
Who is the Target for Screening?
Apparently healthy individuals
Individuals with no clinical symptoms
High-risk populations
Specific age groups or demographics
Screening vs. Diagnosis
Screening Diagnosis
Target Healthy people Symptomatic patients
Purpose Identifies risk Confirms disease
Test Type Simple, low-cost Complex, specific
Scope Population-based Individual-based
Objectives of Screening Programs
Detect diseases at a pre-clinical stage
Reduce disease-related morbidity
Lower mortality rates in the population
Identify high-risk groups effectively
Support early treatment & medical intervention
Encourage lifestyle modification for risk reduction
Reduce healthcare costs by preventing advanced disease
Effective Screening: Disease Criteria
Significant public health impact
Disease must have serious consequences
Must have a detectable preclinical stage
Natural history is well understood
Effective Screening: Test Criteria
High Sensitivity: Ability to detect most cases of the
disease.
Acceptable Specificity: Ensuring low rates of false
positives.
Safe and Simple: The procedure must be non-invasive and
easy to perform.
Affordable and Accessible: Cost-effective for the
population and widely available.
Effective Screening: System Criteria
Availability of confirmatory diagnostic tests
Availability of effective treatment
Infrastructure for follow-up and referral
Types of Understanding Types, Processes, and
Screening Common Applications in Public Health
Mass Screening Applied to the whole
population regardless of risk
status.
Key Characteristics:
Broad reach and large-
scale implementation.
Examples:
Blood pressure screening campaigns.
Blood glucose screening for
the general public.
Selective Screening Applied to high-risk groups only.
Key Characteristics:
Targeted, resource-
efficient, and higher yield.
Examples:
TB screening in healthcare workers.
Hepatitis screening in dialysis patients.
Opportunistic Conducted during routine
Screening healthcare visits.
Key Characteristics:
Unplanned and not part of a formal
program.
Patient-initiated or provider-suggested.
Example:
Pap smear performed during a routine
gynecological exam.
STEP 01 STEP 02
The Screening Identification Selection
Process Identifying the Choosing the most
Steps 1 – 4 target population
for the screening
appropriate and
effective
program. screening test.
STEP 03 STEP 04
Collection Analysis
Gathering Laboratory
necessary processing and
samples from the testing of the
participants. collected
samples.
05 06
The Screening Interpretation Referral
Process Reviewing and Directing patients
Steps 5 – 8 understanding for definitive
results in clinical confirmatory
context. diagnosis.
07 Health 08 Monitoring
Education
Providing Ensuring follow-
counseling and up care and
information to ongoing health
the patient. monitoring.
Cancer Screening: Breast Cancer
Test: Mammography
Target: Women over 40
Purpose: Early tumor detection
Cervical Cancer
Test: Pap smear / HPV test
Target: Sexually active women
Purpose: Detect precancerous changes
Cancer Screening: Colorectal Cancer
Test: FOBT, Colonoscopy
Target: Adults over 50
Purpose: Early detection of
polyps or cancer
"Early detection through
screening significantly
improves survival rates
for these cancers."
Metabolic Disease: Diabetes Mellitus
Tests: Fasting blood glucose, HbA1c
Target: Obese individuals, family history
Benefit: Prevents neuropathy & nephropathy
Hyperlipidemia
Test: Lipid profile
Target: Adults with cardiovascular risk
Benefit: Early detection of high cholesterol
Metabolic Disease: Hypertension Screening
Test: Blood pressure measurement
Target: Individuals with family history
or risk factors
Benefit:
Reduces cardiovascular morbidity
and prevents stroke complications.
Infectious Disease Screening
Objective Public Health Impact
Identify Prevents community
asymptomatic spread and reduces
morbidity.
carriers of
infectious agents. Reduces long-term
healthcare costs.
Blood-borne pathogens (HIV, Hepatitis).
Respiratory infections.
Maternal-to-child transmission prevention.
HIV Screening Strategies
Primary Tests Target Groups Key Benefits
Rapid Antibody Tests Pregnant women Significant
reduction in
ELISA
Blood & organ donors transmission rates
Hepatitis B and C Screening
Targets & Benefits
Screening Markers
Healthcare workers & dialysis patients
→HBsAg
Blood donors & high-risk exposures
: Hepatitis B Surface Antigen
→anti-HCV
• Prevents progression to cirrhosis &
: Hepatitis C Antibodies
liver cancer
Tuberculosis (TB) Screening
Diagnostic Tools Target Populations
Sputum Microscopy High-risk groups (e.g.,
immunocompromised)
Mantoux Test (TST) Close contacts of active cases
Public Health Benefit
Breaks the chain of infection
Enables early treatment
Neonatal Screening: A Vital Start
Systematic testing of newborns for
metabolic and genetic disorders.
Timing & Goal
Performed within the first few days of life.
Identifies conditions not clinically apparent at birth.
Enables immediate intervention to prevent permanent
damage.
Key Neonatal Screening Conditions
PKU Hypothyroidism G6PD
•
Phenylketonuria Congenital Hypothyroidism G6PD Deficiency
Thyroid hormone
• Inability to metabolize • deficiency at birth. • Enzyme defect affecting
phenylalanine. red blood cells.
•
Intervention: •
Intervention:
• Risk:
Strict low-protein Oral levothyroxine.
diet. Hemolytic crises from
• Goal: triggers (beans).
• Goal: Ensure normal
physical & mental Goal:
Prevent severe intellectual growth. Avoidance of
disability. oxidative stressors.
Early detection is Education on trigger
Prevents irreversible
critical for brain avoidance is key.
developmental delays.
development.
Role of the Laboratory in Screening
1. Pre-Analytical Phase
Technical Preparation Safety & Engagement
Test Selection: Compliance:
Using validated screening Adherence to infection
tools appropriate for the control and biosafety
population. standards.
Sample Integrity: Community Education:
Strict protocols for Instructing
collection, labeling, participants on proper
and transport. sample preparation.
2. Analytical Phase
Precision & Standardization Quality Control
Strict adherence to
standardized protocols QC checks to reduce
Ensuring accurate testing false positive
through validated methods. & false negative
Minimizing technical
variability in results.
3. Post-Analytical Phase
Prompt Reporting
• Delivering results quickly to facilitate follow-up.
Abnormal Results
• Clear flagging and referral systems for further diagnosis.
Data Tracking
• Maintaining screening databases for longitudinal
statistics and program evaluation.
Sensitivity in Screening
The ability of a test to correctly identify
individuals with the disease.
Key Implications
High Sensitivity = Few False Negatives .
Sensitivity = TP
Ensures that most diseased individuals are / (TP + FN)
detected.
Critical for serious conditions where missing
a case has severe consequences.
Specificity in Screening
The ability of a test to correctly identify
individuals who do NOT have the disease.
Key Implications
Specificity = TN
High Specificity = Few False Positives . / (TN + FP)
Ensures that healthy individuals are not
mislabeled.
Crucial to avoid unnecessary anxiety and
invasive follow-up procedures.
Evaluation of Screening Programs
Clinical Impact Program Efficiency
Detection Rates: Cost-Effectiveness:
How many cases are being identified? Balancing costs vs. health benefits.
Morbidity: Population Coverage:
Reduction in disease complications. Reaching the target demographic.
Mortality: Continuous Improvement:
Measurable reduction in death rates. Regular assessment to optimize performance.